Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sun Diagnostics is a private U.S. in vitro diagnostics company focused on products that support laboratory medicine, assay validation, and analytical quality. The company develops and sells interference testing kits, quality-control materials, immunoprecipitation reagents, and specialized assay products for researchers, clinical laboratories, and diagnostic manufacturers. Its flagship ASSURANCE product line is designed to simplify interference testing for common assay interferents such as lipemia, hemolysis, bilirubin, protein, and biotin. Sun Diagnostics also offers products including a rapid biotin assay, LipoSep IP immunoprecipitation reagent, and an Lp(a)-P ELISA. The business appears to be a small, active, founder-led diagnostics/tools company based in Maine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sun Diagnostics.